Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 8 | $323,415 |
| Sells | 18 | $31,129,197 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 17 Jul 2024 14:52 | PHAT | Phathom Pharmaceuticals Inc | NABULSI AZMI | Chief Operating Officer | 15 Jul 2024 | Sale | 10,901 | 11.72 | 127,760 | D |
| 17 Jul 2024 14:51 | PHAT | Phathom Pharmaceuticals Inc | HENDERSON MOLLY | CFO and CBO | 15 Jul 2024 | Sale | 4,325 | 11.72 | 50,689 | D |
| 17 Jul 2024 14:50 | PHAT | Phathom Pharmaceuticals Inc | CURRAN TERRIE | President and Chief Executive | 15 Jul 2024 | Sale | 33,848 | 11.72 | 396,699 | D |
| 10 Apr 2024 16:30 | PHAT | Phathom Pharmaceuticals Inc | HENDERSON MOLLY | CFO and CBO | 08 Apr 2024 | Sale | 3,435 | 11.1 | 38,128 | D |
| 26 Mar 2024 16:05 | PHAT | Phathom Pharmaceuticals Inc | CURRAN TERRIE | President and Chief Executive | 22 Mar 2024 | Sale | 16,851 | 9.11 | 153,513 | D |
| 25 Jan 2024 06:13 | PHAT | Phathom Pharmaceuticals Inc | TAKEDA PHARMACEUTICAL CO LTD | 10% | 24 Jan 2024 | Sale | 3,703,703 | 8.1 | 29,999,994 | D |
| 22 Jan 2024 20:22 | PHAT | Phathom Pharmaceuticals Inc | HENDERSON MOLLY | CFO and CBO | 19 Jan 2024 | Sale | 6,307 | 7.7533 | 48,900 | D |
| 21 Nov 2023 16:40 | PHAT | Phathom Pharmaceuticals Inc | HENDERSON MOLLY | CFO and CBO | 20 Nov 2023 | Sale | 2,127 | 7.2415 | 15,403 | D |
| 08 Nov 2023 19:56 | PHAT | Phathom Pharmaceuticals Inc | PARIKH ASIT | Director | 08 Nov 2023 | Purchase | 2,500 | 7.8 | 19,500 | D |
| 08 Nov 2023 19:56 | PHAT | Phathom Pharmaceuticals Inc | PARIKH ASIT | Director | 07 Nov 2023 | Purchase | 4,000 | 7.76 | 31,040 | D |
| 08 Nov 2023 19:56 | PHAT | Phathom Pharmaceuticals Inc | PARIKH ASIT | Director | 06 Nov 2023 | Purchase | 1,000 | 8.04 | 8,040 | D |
| 03 Nov 2023 16:55 | PHAT | Phathom Pharmaceuticals Inc | HENDERSON MOLLY | CFO and CBO | 01 Nov 2023 | Sale | 11,681 | 8.95 | 104,545 | D |
| 03 Nov 2023 16:55 | PHAT | Phathom Pharmaceuticals Inc | HENDERSON MOLLY | CFO and CBO | 01 Nov 2023 | Sale | 811 | 7.8 | 6,326 | D |
| 05 Jun 2023 18:32 | PHAT | Phathom Pharmaceuticals Inc | HENDERSON MOLLY | CFO and CBO | 02 Jun 2023 | Sale | 1,960 | 11.4121 | 22,368 | D |
| 23 May 2023 12:15 | PHAT | Phathom Pharmaceuticals Inc | HENDERSON MOLLY | CFO and CBO | 22 May 2023 | Sale | 2,110 | 12.8744 | 27,165 | D |
| 11 Apr 2023 16:05 | PHAT | Phathom Pharmaceuticals Inc | PARIKH ASIT | Director | 10 Apr 2023 | Purchase | 1,000 | 7.55 | 7,550 | D |
| 11 Apr 2023 16:05 | PHAT | Phathom Pharmaceuticals Inc | NABULSI AZMI | Chief Operating Officer | 11 Apr 2023 | Purchase | 10,000 | 8.26 | 82,600 | D |
| 07 Apr 2023 15:19 | PHAT | Phathom Pharmaceuticals Inc | CURRAN TERRIE | President and Chief Executive | 06 Apr 2023 | Purchase | 12,919 | 7.8199 | 101,025 | D |
| 07 Apr 2023 15:18 | PHAT | Phathom Pharmaceuticals Inc | HENDERSON MOLLY | CFO and CBO | 06 Apr 2023 | Sale | 3,439 | 7.27 | 25,002 | D |
| 03 Mar 2023 19:03 | PHAT | Phathom Pharmaceuticals Inc | HENDERSON MOLLY | CFO and CBO | 01 Mar 2023 | Sale | 2,032 | 8.5309 | 17,335 | D |
| 03 Mar 2023 18:59 | PHAT | Phathom Pharmaceuticals Inc | CURRAN TERRIE | President and Chief Executive | 01 Mar 2023 | Sale | 1,436 | 8.5411 | 12,265 | D |
| 14 Feb 2023 16:56 | PHAT | Phathom Pharmaceuticals Inc | PARIKH ASIT | Director | 13 Feb 2023 | Purchase | 5,000 | 7.732 | 38,660 | D |
| 20 Jan 2023 19:39 | PHAT | Phathom Pharmaceuticals Inc | CURRAN TERRIE | President and Chief Executive | 20 Jan 2023 | Sale | 5,821 | 8.1995 | 47,729 | D |
| 12 Jan 2023 16:32 | PHAT | Phathom Pharmaceuticals Inc | PARIKH ASIT | Director | 12 Jan 2023 | Purchase | 5,000 | 7 | 35,000 | D |
| 23 Nov 2022 16:10 | PHAT | Phathom Pharmaceuticals Inc | HENDERSON MOLLY | CFO and CBO | 21 Nov 2022 | Sale | 2,159 | 9.6 | 20,726 | D |
| 23 Nov 2022 16:07 | PHAT | Phathom Pharmaceuticals Inc | CURRAN TERRIE | President and Chief Executive | 21 Nov 2022 | Sale | 1,526 | 9.6 | 14,650 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)